Health
New antitumor vaccines control melanoma growth in preclinical models – News-Medical.Net
Combining their expertise in protein engineering and synthetic DNA technology, scientists at The Wistar Institute successfully delivered nanoparticle antitumor vaccines that stimulated robust CD8 T cell immunity and controlled melanoma growth in preclinical m…
Reviewed by Emily Henderson, B.Sc.Sep 11 2020
Combining their expertise in protein engineering and synthetic DNA technology, scientists at The Wistar Institute successfully delivered nanoparticle antitumor vaccines that stimulated robust CD8 T cell immunity and controlled melanoma growth in preclinical models.
Study results were published online in Cancer Immunology Research, a journal of the American Association for Cancer Research, and support exploration of this immunotherapy approach for a…
-
General15 hours agoVictorian school teacher charged with soliciting child abuse material
-
Business24 hours agoWhy did this ASX 200 healthcare stock crash 14% yesterday?
-
Business23 hours agoHere’s what analysts expect for the BHP share price in the coming year
-
General23 hours agoPatients speak out after Brisbane doctor accused of ‘excessive’ pap smears, kissing woman on lips